In other cases (e.g., monoclonal antibodies), the objective of protein engineering was to generate a product displaying reduced immunogenicity. Early monoclonals, because of their murine origin ...

Last year was a vintage year for the bio-pharmaceutical industry in two respects. Four monoclonal antibodies (mAbs) gained approval in 2009, representing the highest annual number in over a decade.

After hours: February 7 at 4:03:16 PM EST Loading Chart for YMAB ...

Patients who developed antiadalimumab antibodies (AAA) during a 3 year time period achieved less often minimal disease activity or remission and treatment failure occurred more often compared with ...

The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...

The management of Leishmania donova ni (LD), responsible for fatal visceral leishmaniasis (VL), faces increasing challenges due to rising drug-unresponsiveness, leading to increasing treatment ...